← 홈

IBD (크론·대장) · TNF-α

57개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 57개
AntibodystaleJanssenApproved

CYCLOSPORINE VS INFLIXIMAB (CYCLOSPORINE VS INFLIXIMAB)

Ulcerative Colitis; Steroid Refractory · FRα

#FR#Antibody#Approved#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleFundación de Investigación Biom…Preclinical

ustekinumab (Stelara, Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 2

adalimumab (Humira, FITC-Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

IFX alone (Infliximab, Infliximab (IFX alone))

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

IFX (Infliximab, Infliximab (IFX))

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenApproved

adalimumab (Humira, Infliximab Adalimumab y Golimumab)

Ulcerative Colitis; Thromboembolism · Ulcerative Colitis

#UlcerativeColitis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab CT-P13 (Infliximab CT-P13)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab Dose Intensification (Infliximab Dose Intensification)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 1

Infliximab Treatment (Infliximab Treatment)

Ulcerative Colitis Chronic Moderate; Ulcerative Colitis Chronic Severe · Ulcerative Colitis Chronic Moderate

#UlcerativeColitisChronicModerate#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab and immunosuppressives (Infliximab and immunosuppressives)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Infliximab at weeks 0 and 8 (Infliximab at weeks 0 and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0,2, and 6 (Infliximab at weeks 0,2, and 6)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0,4, and 8 (Infliximab at weeks 0,4, and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPreclinical

Infliximab combined with azathioprine therapy (Infliximab combined with azathioprine therapy)

Crohn's Diseases; Crohn's Disease in Pediatric Patient · Crohn's Diseases

#CrohnsDiseases#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPreclinical

Infliximab monotherapy (Infliximab monotherapy)

Crohn's Diseases; Crohn's Disease in Pediatric Patient · Crohn's Diseases

#CrohnsDiseases#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

ustekinumab (Stelara, Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib)

Inflammatory Bowel Diseases; Crohn Disease · Inflammatory Bowel Diseases

#InflammatoryBowelDiseases#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab precision dosing (Infliximab precision dosing)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

IIFX + AZA (Infliximab with azathioprine, Infliximab with azathioprine (IIFX + AZA))

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, Infliximab, adalimumab, certolizumab pegol)

Inflammatory Bowel Disease; Crohn's Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

Infliximab-Dyyb (Infliximab-Dyyb)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING

2 / 3 페이지

← 이전다음 →